SynthesisFrontiers in medicine2026

Infection risk in inflammatory bowel disease patients treated with vedolizumab: a systematic review and meta-analysis.

Lidan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.